Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if late doses of Infasurf surfactant given when
patients are receiving inhaled nitric oxide will interact to improve surfactant function and
increase survival without BPD in treated infants.
Phase:
Phase 3
Details
Lead Sponsor:
Roberta Ballard University of California, San Francisco